EGFR-targeting drugs in combination with cytotoxic agents: from bench to bedside, a contrasted reality

The clinical experience recently reported with epidermal growth factor receptor (EGFR)-targeting drugs confirms the synergistic interactions observed between these compounds and conventional cytotoxic agents, which were previously established at the preclinical stage. There are, however, examples of...

Descripción completa

Detalles Bibliográficos
Autores principales: Milano, G, Spano, J-P, Leyland-Jones, B
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453033/
https://www.ncbi.nlm.nih.gov/pubmed/18506149
http://dx.doi.org/10.1038/sj.bjc.6604373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2453033/
https://www.ncbi.nlm.nih.gov/pubmed/18506149
http://dx.doi.org/10.1038/sj.bjc.6604373

Ejemplares similares